手术治疗趋势和隐匿性乳腺癌术后原发性乳腺肿瘤的识别:一项基于日本国家临床数据库-乳腺癌登记处的研究。

IF 2.9
Breast cancer (Tokyo, Japan) Pub Date : 2022-07-01 Epub Date: 2022-03-22 DOI:10.1007/s12282-022-01348-y
Mitsuo Terada, Minoru Miyashita, Hiraku Kumamaru, Hiroaki Miyata, Kenji Tamura, Masayuki Yoshida, Etsuyo Ogo, Masayuki Nagahashi, Sota Asaga, Yasuyuki Kojima, Takayuki Kadoya, Kenjiro Aogi, Naoki Niikura, Kotaro Iijima, Naoki Hayashi, Makoto Kubo, Yutaka Yamamoto, Hiromitsu Jinno
{"title":"手术治疗趋势和隐匿性乳腺癌术后原发性乳腺肿瘤的识别:一项基于日本国家临床数据库-乳腺癌登记处的研究。","authors":"Mitsuo Terada,&nbsp;Minoru Miyashita,&nbsp;Hiraku Kumamaru,&nbsp;Hiroaki Miyata,&nbsp;Kenji Tamura,&nbsp;Masayuki Yoshida,&nbsp;Etsuyo Ogo,&nbsp;Masayuki Nagahashi,&nbsp;Sota Asaga,&nbsp;Yasuyuki Kojima,&nbsp;Takayuki Kadoya,&nbsp;Kenjiro Aogi,&nbsp;Naoki Niikura,&nbsp;Kotaro Iijima,&nbsp;Naoki Hayashi,&nbsp;Makoto Kubo,&nbsp;Yutaka Yamamoto,&nbsp;Hiromitsu Jinno","doi":"10.1007/s12282-022-01348-y","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Occult breast cancer (OBC) is classified as carcinoma of an unknown primary site, and the adequate therapy for OBC remains controversial. This retrospective study aimed to reveal the transition in breast cancer therapy and the frequency of primary breast tumors after resection in clinical OBC (cT0N+) patients using the Japanese Breast Cancer Registry database.</p><p><strong>Methods: </strong>We enrolled OBC patients with cT0N+ from the registry between 2010 and 2018. On the basis of the period of diagnosis, OBC patients were divided into the following two groups: 2010-2014 and 2015-2018. We described the transition in treatments and tumor characteristics. After breast resection, the frequency of pathological identification of primary tumors and tumor sizes was assessed.</p><p><strong>Results: </strong>Of the 687,468 patients registered, we identified 148 cT0N+ patients with a median age of 61 years. Of these patients, 64.2% (n = 95) received breast surgery (2010-2014: 79.1%, 2015-2018: 50.0%). Axillary lymph node dissection was performed in 92.6% (n = 137, 2010-2014: 91.6%, 2015-2018: 93.4%). The breast tumor size in the resected breast was 0-7.0 cm (median: 0 cm, 2010-2014: 0-7.0 cm [median: 0 cm], 2015-2018: 0-6.2 cm [median: 0 cm]). The pathological identification rate of the primary tumor was 41.1% (n = 39, 2010-2014: 40.4%, 2015-2018: 42.1%).</p><p><strong>Conclusions: </strong>Breast surgery for cT0N+ decreased between 2010 and 2018. Despite the high identification rate of primary tumors, most tumors were small, and there was no significant change in the identification rate or invasive diameter of the identified tumors after 2010.</p>","PeriodicalId":520574,"journal":{"name":"Breast cancer (Tokyo, Japan)","volume":" ","pages":"698-708"},"PeriodicalIF":2.9000,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":"{\"title\":\"Surgical treatment trends and identification of primary breast tumors after surgery in occult breast cancer: a study based on the Japanese National Clinical Database-Breast Cancer Registry.\",\"authors\":\"Mitsuo Terada,&nbsp;Minoru Miyashita,&nbsp;Hiraku Kumamaru,&nbsp;Hiroaki Miyata,&nbsp;Kenji Tamura,&nbsp;Masayuki Yoshida,&nbsp;Etsuyo Ogo,&nbsp;Masayuki Nagahashi,&nbsp;Sota Asaga,&nbsp;Yasuyuki Kojima,&nbsp;Takayuki Kadoya,&nbsp;Kenjiro Aogi,&nbsp;Naoki Niikura,&nbsp;Kotaro Iijima,&nbsp;Naoki Hayashi,&nbsp;Makoto Kubo,&nbsp;Yutaka Yamamoto,&nbsp;Hiromitsu Jinno\",\"doi\":\"10.1007/s12282-022-01348-y\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Occult breast cancer (OBC) is classified as carcinoma of an unknown primary site, and the adequate therapy for OBC remains controversial. This retrospective study aimed to reveal the transition in breast cancer therapy and the frequency of primary breast tumors after resection in clinical OBC (cT0N+) patients using the Japanese Breast Cancer Registry database.</p><p><strong>Methods: </strong>We enrolled OBC patients with cT0N+ from the registry between 2010 and 2018. On the basis of the period of diagnosis, OBC patients were divided into the following two groups: 2010-2014 and 2015-2018. We described the transition in treatments and tumor characteristics. After breast resection, the frequency of pathological identification of primary tumors and tumor sizes was assessed.</p><p><strong>Results: </strong>Of the 687,468 patients registered, we identified 148 cT0N+ patients with a median age of 61 years. Of these patients, 64.2% (n = 95) received breast surgery (2010-2014: 79.1%, 2015-2018: 50.0%). Axillary lymph node dissection was performed in 92.6% (n = 137, 2010-2014: 91.6%, 2015-2018: 93.4%). The breast tumor size in the resected breast was 0-7.0 cm (median: 0 cm, 2010-2014: 0-7.0 cm [median: 0 cm], 2015-2018: 0-6.2 cm [median: 0 cm]). The pathological identification rate of the primary tumor was 41.1% (n = 39, 2010-2014: 40.4%, 2015-2018: 42.1%).</p><p><strong>Conclusions: </strong>Breast surgery for cT0N+ decreased between 2010 and 2018. Despite the high identification rate of primary tumors, most tumors were small, and there was no significant change in the identification rate or invasive diameter of the identified tumors after 2010.</p>\",\"PeriodicalId\":520574,\"journal\":{\"name\":\"Breast cancer (Tokyo, Japan)\",\"volume\":\" \",\"pages\":\"698-708\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2022-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"5\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Breast cancer (Tokyo, Japan)\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s12282-022-01348-y\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/3/22 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Breast cancer (Tokyo, Japan)","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12282-022-01348-y","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/3/22 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5

摘要

背景:隐匿性乳腺癌(OBC)被归类为原发部位未知的癌症,对OBC的适当治疗仍然存在争议。本回顾性研究旨在利用日本乳腺癌注册数据库揭示临床OBC (cT0N+)患者乳腺癌治疗的转变和切除后原发性乳腺肿瘤的频率。方法:我们从2010年至2018年的登记处招募了cT0N+的OBC患者。根据诊断时间将OBC患者分为2010-2014年和2015-2018年两组。我们描述了治疗方法和肿瘤特征的转变。乳房切除术后,评估原发肿瘤的病理鉴定频率和肿瘤大小。结果:在登记的687,468例患者中,我们确定了148例cT0N+患者,中位年龄为61岁。其中64.2% (n = 95)的患者接受了乳房手术(2010-2014年:79.1%,2015-2018年:50.0%)。腋窝淋巴结清扫占92.6% (n = 137, 2010-2014年:91.6%,2015-2018年:93.4%)。切除乳腺肿瘤大小为0-7.0 cm(中位数:0 cm, 2010-2014年:0-7.0 cm[中位数:0 cm], 2015-2018年:0-6.2 cm[中位数:0 cm])。原发肿瘤病理检出率为41.1% (n = 39, 2010-2014: 40.4%, 2015-2018: 42.1%)。结论:2010年至2018年间,cT0N+的乳房手术减少。虽然原发肿瘤的检出率较高,但大多数肿瘤较小,2010年以后所发现肿瘤的检出率和浸润直径没有明显变化。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Surgical treatment trends and identification of primary breast tumors after surgery in occult breast cancer: a study based on the Japanese National Clinical Database-Breast Cancer Registry.

Background: Occult breast cancer (OBC) is classified as carcinoma of an unknown primary site, and the adequate therapy for OBC remains controversial. This retrospective study aimed to reveal the transition in breast cancer therapy and the frequency of primary breast tumors after resection in clinical OBC (cT0N+) patients using the Japanese Breast Cancer Registry database.

Methods: We enrolled OBC patients with cT0N+ from the registry between 2010 and 2018. On the basis of the period of diagnosis, OBC patients were divided into the following two groups: 2010-2014 and 2015-2018. We described the transition in treatments and tumor characteristics. After breast resection, the frequency of pathological identification of primary tumors and tumor sizes was assessed.

Results: Of the 687,468 patients registered, we identified 148 cT0N+ patients with a median age of 61 years. Of these patients, 64.2% (n = 95) received breast surgery (2010-2014: 79.1%, 2015-2018: 50.0%). Axillary lymph node dissection was performed in 92.6% (n = 137, 2010-2014: 91.6%, 2015-2018: 93.4%). The breast tumor size in the resected breast was 0-7.0 cm (median: 0 cm, 2010-2014: 0-7.0 cm [median: 0 cm], 2015-2018: 0-6.2 cm [median: 0 cm]). The pathological identification rate of the primary tumor was 41.1% (n = 39, 2010-2014: 40.4%, 2015-2018: 42.1%).

Conclusions: Breast surgery for cT0N+ decreased between 2010 and 2018. Despite the high identification rate of primary tumors, most tumors were small, and there was no significant change in the identification rate or invasive diameter of the identified tumors after 2010.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信